Stocks rally on vaccine hopes — three investors on what's next

Stocks rallied to begin the week after Pfizer and BioNTech's Covid-19 vaccine candidates received "fast-track" status. Here's what strategists and portfolio managers say is next for the second half of the year and how investors should be prepared.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.